Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Phreesia held its annual stockholder meeting on June 25, 2025, where three key proposals were voted on. The meeting results revealed significant shareholder participation and support for the company's initiatives.
Key voting outcomes:
- Director Elections: Gillian Munson received strong support with 47.3M votes (91.6% approval), while Mark Smith, M.D. secured 37.7M votes (73% approval) for Class III director positions with three-year terms expiring in 2028
- Auditor Appointment: Shareholders overwhelmingly approved KPMG LLP as the independent auditor for FY2026, with 99.9% voting in favor (53.6M votes)
- Executive Compensation: The say-on-pay proposal passed with 90.5% approval (46.7M votes in favor), demonstrating strong shareholder support for the company's executive compensation practices
The voting results indicate robust shareholder engagement, with relatively low abstention rates and clear majorities on all proposals, though notably lower support for Dr. Smith's director election compared to his fellow nominee.
Form 4 Filing Details: David Linetsky, SVP of Network Solutions at Phreesia (PHR), reported insider transactions executed on June 17-18, 2025. The transactions involved mandatory sell-to-cover dispositions to satisfy tax withholding obligations from restricted stock unit settlements.
Transaction Details:
- June 17: Disposed of 42 shares at weighted average price of $25.1721 (range: $24.68-$25.675)
- June 18: Disposed of 67 shares at weighted average price of $25.6114 (range: $25.255-$25.935)
Post-Transaction Holdings: Following these transactions, Linetsky maintains direct ownership of 217,239 shares, while 9,795 shares are held indirectly by spouse. The sales were non-discretionary, executed under the company's mandatory tax withholding policy for RSU settlements.